⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
globenewswire.com
REGN
MRK
BSX
BDX
TMO
ABT
DHR
BRKR
QDEL
GSK
SPRO
Regen-cov and Ronapreve (F. Hoffmann-La Roche; Regeneron Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
REGN
Giants of Cancer Care® announces the 14th annual class of inductees
globenewswire.com
PFE
REGN
Patient Safety Launches Nationwide
prnewswire.com
MSFT
UNH
HCA
AMZN
CVS
GEHC
BIO
MDLZ
SYK
BMY
PFE
JNJ
ABBV
AMGN
GILD
REGN
BIIB
MRNA
BNTX
XRAY
ISRG
TMDX
HOLX
EW
COO
LH
DGX
CTAS
BRKR
VRTX
ALGN
MDT
BAX
ZBH
VRSN
ADBE
IBM
ORCL
HPQ
DELL
CSCO
INTC
QCOM
MU
AMAT
LRCX
KLAC
ADI
NXPI
MCHP
ON
NVDA
AMD
GOOG
META
AAPL
AVGO
TSLA
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
globenewswire.com
REGN
Biotech’s Next Wave May Already be in Motion
globenewswire.com
NTHI
LLY
NVO
REGN
Spago Nanomedical Interim Report January-March 2026
accessnewswire.com
TLRY
BMY
REGN
Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight
globenewswire.com
CRSP
TMO
EDIT
LGL
SANG
PRGS
CELC
REGN
ILMN
MYGN
BIIB
DHR
ROST
QGEN
DGX
ABT
MRK
PACB
AZTA
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight
globenewswire.com
ADAG
ABBV
BIIB
BMRN
BLRX
CNSP
CYCN
GEN
GILD
GRAF
GSK
HSIC
HUBS
IBIO
INCY
JAZZ
JNJ
MAGN
MARA
MRK
NVS
OMER
PFE
PRGS
REGN
RGNX
SRPT
TENB
TGLS
TGTX
TNDM
TXG
VRTX
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP